| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 83.4× | 27.9× | |
| Price / Book | 9.9× | 4.1× | |
| Price / Sales | 11.0× | 2.9× | |
| Price / Free cash flow | −29.3× | −9.5× | |
| EV / EBITDA | 44.9× | 21.7× | |
| Earnings yield | 1.2% | 2.1% | |
| Free cash flow yield | −3.4% | −3.1% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹646.50 | +0.59% | $11.76B | 226.5× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,508.60 | +2.13% | $2.57B | 99.0× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,574.40 | +10.15% | $1.73B | 113.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,003.90 | −2.00% | $1.32B | 67.6× | 24.8% | — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,402.90 | +2.62% | $361.97M | 51.1× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.88 | +3.13% | $308.69M | 133.1× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,477.70 | +1.07% | $252.5M | 73.6× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹487.30 | +0.70% | $224.86M | 149.9× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,783.00 | +1.87% | $204.09M | 46.8× | 16.9% | −2.0% |
VONSE:VOEPLVirtuoso OptoElectronics Ltd · 🇮🇳 NSE | ₹511.00 | +1.46% | $181.35M | 114.8× | 3.6% | — |
